General Dermatology

The clinically-backed, post-procedure sunscreen is designed to enhance skin healing, reduce redness, promote hydration, and provide broad-spectrum UV protection.

Explore the top headlines of the week including innovation in scalp treatment, therapeutic updates in rosacea, and acne vulgaris insights from James Del Rosso, DO.

In case you missed it, this week we had news about awareness resources from the Skin Cancer Foundation, burn care disparities in skin of color, aesthetic insights for patients on medication-driven weight loss journeys, and more.

Learn more about the in-depth topics covered in the January 2025 print issue of Dermatology Times.

Dermatology Times is looking back on the top stories in dermatology from the month of January.

Dermatology Times is recapping our top expert interviews from the month of January.

James Del Rosso, DO, shared insights on existing and upcoming therapies for seborrheic dermatitis.

Explore the top headlines of the week including clinical trial updates, social media hair trends, and expert insights.

In case you missed it, this week we had news about the link between psoriasis and dementia, the future of urticaria treatment, VP-315's positive results in basal cell carcinoma, and more.

Personalized care is key to managing hyperhidrosis, blending therapies, addressing adverse effects, and empowering patients with tailored solutions.

Understanding urticaria subtypes, from spontaneous to inducible, is key to crafting patient-specific management plans.

According to a phase 3 study, the omalizumab biosimilar saw comparable results with a good safety profile.

In his presentation at Winter Clinical Miami, Del Rosso covered new and emerging therapies as well as successful off-label uses.

Attovia is also advancing 4 ATTOBODY-based programs for inflammatory conditions, such as atopic dermatitis and IBD.

Adam Friedman, MD, FAAD, takes a closer look at the emerging landscape of oral treatments for hyperhidrosis and what lies ahead in advancing patient care.

Jason Hawkes, MD, MS, discusses unmet needs in chronic urticaria care and challenges outdated testing practices.

Fast-acting therapies like remibrutinib bring new hope to patients with chronic urticaria who don’t respond to antihistamines.

Hawkes combines personal experience and clinical expertise to treat urticaria patients.

Explore the top headlines of the week including the growth of NPs and PAs in the field, clinical trial updates, and advancements in therapy.

In case you missed it, this week we had news about AIs and CNNs for early melanoma detection, OCT Technology for vitiligo imaging, UCB’s 320mg single-injection bimekizumab, and more.

A recent study evaluated the efficacy of low-energy delicate pulsed light photomodulation for treating sensitive skin, showing significant improvements in symptoms and erythema.

Mitragotri's work bridges advanced drug development and skin care for tailored treatments.

The new dosing option offers convenience for those managing plaque psoriasis, PsA, and hidradenitis suppurativa.

Soligenix recently shared interim results from a 12-month investigator-initiated study of synthetic hypericin.

A study found that UK adults living with psoriasis and vitiligo were better able to self-manage the psychological implications of their condition.

In case you missed it, this week we had news about phase 2b enrollment for VYNE’s vitiligo gel, the impact of anti-inflammatory moisturizers for AD, the newly FDA-approved DermiSphere hDRT, and more.

Explore the top headlines of the week including clinical trial updates, FDA announcements, and expert insights.

Advancements in therapeutic agents demand innovative strategies for safe, localized skin treatments, Mitragotri argues.

Mitragotri said new innovations like ionic liquid-based delivery systems can offer better treatment for immunodermatological conditions.

UVF dermoscopy enhances scabies detection, especially in dark skin, with optimal results when combined with polarized light examination.